Kedrion strengthens its network of plasma collection centers
Dec 05, 2022 |
CORPORATE
Five centers acquired in the Czech Republic
Permira Funds and the Marcucci family complete investment in Kedrion & BPL
Sep 01, 2022 |
CORPORATE
Announced appointment of Ugo Di Francesco as CEO
Kedrion alongside the World Hepatitis Alliance
Jul 28, 2022 |
EVENTS
The company is proud to support WHA’s initiative aimed at preventing mother-to-child transmission (PMTCT) of Hepatitis B
Kedrion Biopharma Recognized for innovation in Treating Rare Disease
Jun 28, 2022 |
CORPORATE
Prestigious recognition presented for the first ever treatment for Plasminogen Deficiency
Kedrion and IPOPI: the journey continues at the 2022 IPIC
Apr 29, 2022 |
EVENTS
The Primary Immunodeficiencies International Congress took place during World PI Week
World Hemophilia Day: Kedrion’s commitment
Apr 13, 2022 |
CORPORATE
Guaranteeing equitable access to treatment is the central theme of the 2022 edition
Kedrion-Pharmacosmos partnership for the treatment of Anemia in Italy
Mar 03, 2022 |
CORPORATE
Exclusive agreement signed for the distribution of a novel iron-based therapy
Val Romberg completes his assignement as Kedrion’s CEO
Jan 31, 2022 |
CORPORATE
Kedrion and LFB sign industrial cooperation agreement
Jan 31, 2022 |
CORPORATE
Scope is supplying Immunoglobulins to meet patient demand in France